Hematology - European Medical Journal

Continue

Hematology

Filter
11 Mins
31 Aug 2017

Inherited Bone Failure Syndromes, Focus on the Haematological Manifestations: A Review

The purpose of this review is to provide the haematologist with a working knowledge of the common inherited bone marrow failure syndromes (iBMFS)…
10 Mins
31 Aug 2017

Non-Classic Myeloproliferative Neoplasms: Are We Really Aware of These Rare Diseases in Daily Practice?

Chronic neutrophilic leukaemia (CNL), chronic eosinophilic leukaemia-not otherwise specified (CEL-NOS), and myeloproliferative neoplasm (MPN)…
8 Mins
31 Aug 2017

Novel Immunotherapy Agents for Acute Lymphoblastic Leukaemia

Acute lymphoblastic leukaemia (ALL) in adults has a survival rate of 40–50% at 5 years, with a high relapse rate after first-line chemotherapy.
3 Mins
9 Aug 2017

Spasmodic Dysphonia: What About It?

Spasmodic dysphonia (SD): what about it? That is the million-dollar question.
9 Mins
8 Aug 2017

Improving Treatment Strategies for Patients with Follicular Lymphoma: How to Translate Novel Study Data into Clinical Practice

Ms Rosmarie Pfau detailed the challenges faced by patients with FL around the world, particularly a desire for improved quality of life (QoL) and…
9 Mins
8 Aug 2017

Shifting Treatment Paradigms in Non-Hodgkin Lymphomas

Despite significant therapeutic advances in the treatment of patients with non-Hodgkin lymphoma (NHL), a significant proportion experience relapse or…
9 Mins
8 Aug 2017

Biosimilars for Haematologic Malignancies: The Path to Sustainable Care

The main objectives of this symposium were to review the value of biosimilars in sustainable treatment for haematologic malignancies and to recognise the…
9 Mins
8 Aug 2017

Patients in Focus: What’s Relevant for Chronic Myeloid Leukaemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia?

This symposium was dedicated to discussing BCR-ABL-positive chronic myeloid leukaemia (CML) and Philadelphia-positive acute lymphoblastic leukaemia (Ph+ALL)
We’ve noticed you’re accessing
from North/South America.